Neuregulin 1 antibody (Middle Region)
Quick Overview for Neuregulin 1 antibody (Middle Region) (ABIN634812)
Target
See all Neuregulin 1 (NRG1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- NRG1 antibody was raised against the middle region of NRG1
-
Purification
- Affinity purified
-
Immunogen
- NRG1 antibody was raised using the middle region of NRG1 corresponding to a region with amino acids SEVQVTVQGDKAVVSFEPSAAPTPKNRIFAFSFLPSTAPSFPSPTRNPEV
-
-
-
-
Application Notes
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
NRG1 Blocking Peptide, (ABIN5615062), is also available for use as a blocking control in assays to test for specificity of this NRG1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NRG1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Neuregulin 1 (NRG1)
-
Alternative Name
- NRG1
-
Background
- Neuregulin 1 (NRG1) was originally identified as a 44 kDa glycoprotein that interacts with the NEU/ERBB2 receptor tyrosine kinase to increase its phosphorylation on tyrosine residues. It is known that an extraordinary variety of different isoforms are produced from the NRG1 gene by alternative splicing.
-
Molecular Weight
- 32 kDa (MW of target protein)
-
Pathways
- RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Muscle Cell Differentiation
Target
-